Navigating the translational Valley of death in oncology nanotheranostics: manufacturing, biological, clinical, and regulatory barriers to implementation.
- DOI
- 10.1080/17435889.2026.2705388
- Published
- 2026 Aug
- Container
- Nanomedicine (London, England)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/17435889.2026.2705388,
title = {Navigating the translational Valley of death in oncology nanotheranostics: manufacturing, biological, clinical, and regulatory barriers to implementation.},
author = {Alum EU and Obasi DC and Uzor S and Eji MO and Amadi EB and Emeruwa AP and Akwari AA and Okoroh PN and Aniokete UC and Alum BN},
year = {2026},
journal = {Nanomedicine (London, England)},
doi = {10.1080/17435889.2026.2705388},
url = {https://doi.org/10.1080/17435889.2026.2705388}
}RIS
TY - JOUR TI - Navigating the translational Valley of death in oncology nanotheranostics: manufacturing, biological, clinical, and regulatory barriers to implementation. AU - Alum EU AU - Obasi DC AU - Uzor S AU - Eji MO AU - Amadi EB AU - Emeruwa AP AU - Akwari AA AU - Okoroh PN AU - Aniokete UC AU - Alum BN PY - 2026 JO - Nanomedicine (London, England) DO - 10.1080/17435889.2026.2705388 UR - https://doi.org/10.1080/17435889.2026.2705388 ER -
APA
EU, A., DC, O., S, U., MO, E., EB, A., AP, E., AA, A., PN, O., UC, A., & BN, A. (2026). Navigating the translational Valley of death in oncology nanotheranostics: manufacturing, biological, clinical, and regulatory barriers to implementation.. Nanomedicine (London, England). https://doi.org/10.1080/17435889.2026.2705388
Source records
- pubmed · retrieved 2026-09-26T20:22:45.858Z